NBB and Buckeyes I believe we are all thinking on the same lines. I'm wondering if now is the time that some of these companies with expiring patents are now more motivated to look at drug candidates like ABL more seriously. 

If for some reason one or more of those companies do not want to deal with our current management would that be able to be resolved by them letting the investment bankers know and finding a work around? When I looked at the history of Imunometics years ago that seemed to be what happened a year or so before that monster deal was done.

tada